viewTrakm8 Holdings PLC

Trakm8 cuts loss after putting brakes on revenue decline

The company, which supplies telematics equipment to track vehicles, chopped a quarter off its loss before tax as revenues and margins rose, and said it expected a better second half of the year

Trakm8 Holdings PLC -

Trakm8 Holdings PLC (LON:TRAK) has narrowed half-year losses despite recurring revenues at the fleet management and telematics outfit being hit by its largest insurance customer seeing an ongoing decline in young driver policies.

Pre-tax losses came in at £2.2mln in the six months to the end of September, reduced by a quarter from £2.9mln the previous year.

READ: Telematics group Trakm8 blasts sales team as it swings to a loss

Trakm8 said this was down to flat revenues of £8.9mln coupled with an increasing gross profit margin of 53% due to “vigorous actions taken over the past 12 months” including cutting hardware costs and reducing direct labour costs.

Nevertheless, recurring revenues, which represent 55% of the total sales, fell 5% to £4.9mln, thanks to a decline in the revenue per unit in the insurance market and decline in install base of its largest insurance customer.

“Our largest insurance customer has continued to experience a decline in young driver policies and as a result the level of new policies written has been less than those not renewed or cancelled,” said Trakm8, having in July reported this issue meant fewer telematics boxes were being required.

In addition, its major vehicles customer did not order any more devices during the period, but has made a commitment to buy 45,000 units over the next twelve months.

Trakm8 said: “The board is encouraged that the decline in revenue has been arrested and the first two months of H2 are significantly ahead of last year,” before adding that it expects to meet full year market expectations of increased revenues and modest adjusted profit before tax.

Shares got a 4% boost to 23.5p in early trading on Monday.

Quick facts: Trakm8 Holdings PLC

Price: 22.5 GBX

Market: AIM
Market Cap: £11.24 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

8 hours, 3 minutes ago


Change of Auditor

4 days, 12 hours ago

Director Dealings

1 week, 3 days ago

New Growth Capital Loan

4 weeks, 2 days ago

Half Year Results

on 9/12/19

Director Change

on 1/10/19

Result of AGM

on 26/9/19

2 min read